Skip to content
Wenlo
Sign in
← Markets

Regeneron Pharmaceuticals, Inc.

Regeneron Pharmaceuticals, Inc. (REGN) — Form 144: Proposed sale of shares

144REGNFiled Nov 17, 2026, 4:08 PM ET

AI-generated summary

Officer ANDREW J MURPHY proposed to sell 5,011 shares of Common stock with an aggregate market value of $4,773,278.16 through UBS Financial Services, Inc., following an acquisition of the shares through an exercise of stock options on November 16, 2026. The proposed sale is associated with a trading plan adopted on May 7, 2026.

Key facts

Seller
MURPHY ANDREW J
Relationship
Officer
Shares to sell
5,011
Market value
$4,773,278.16
Approximate sale date
Nov 17, 2026
Broker
UBS Financial Services, Inc.
Acquired
Nov 16, 2026 · Exercise of Stock Options

Rule 10b5-1 plan · adopted May 7, 2026

More REGN filings

Not investment advice. Summaries can contain errors; the SEC filing is the official record.